查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1312084

监管事务市场：按服务、按适应症、按阶段、按类别、按服务提供者、按公司规模、按最终用户 - 2023-2030 年全球预测

Regulatory Affairs Market by Services, Indication, Stage, Category, Service Provider, Company Size, End-Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球监管事务市场将大幅成长156.3亿美元，年复合成长率为10.56%，预计到2030年将达到惊人的317.1亿美元。

FPNV定位矩阵

FPNV 定位矩阵对于评估全球监管事务市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球监理事务市场规模及预测为何？

2.在预测期内，COVID-19 对全球监管事务市场的阻碍因素和影响有哪些？

3. 在预测期内，全球监理事务市场需要投资哪些产品/细分市场/应用/领域？

4. 监管事务在全球市场的竞争策略为何？

5. 全球监管事务市场的技术趋势和法律规范是什么？

6.全球监管事务市场主要供应商的市占率是多少？

7. 监管事务部门适合采取哪些型态和策略措施进入全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 全球药物研发与开发显着成长
      • 医疗保健领域政府法规的变化
      • 罕见病患病率上升和新感染疾病的出现
    • 抑制因素
      • 提供法规服务的成本高昂
    • 机会
      • 主要市场参与者对医疗保健设备开发进行巨额投资
      • 消费者对生物製剂和仿製药的偏好不断增加
    • 任务
      • 与监管事务相关的严格政府政策和法规
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章监理事务市场：依服务分类

  • 合法代表
  • 产品註册及临床试验申请
  • 法规咨询
  • 法规写作和发布

第7章监管事务市场（依指标）

  • 心臟病学
  • 免疫学
  • 神经病学
  • 肿瘤学

第8章监理事务市场：依阶段

  • 临床研究
  • 临床前

第9章监理事务市场：依类别

  • 生物製品
    • 生物相似药
    • 生物技术
  • 药物
    • 通用的
    • 创新者
  • 医用器材
    • 诊断
    • 疗法

第10章服务提供者监管事务市场

  • 公司内部
  • 外包

第11章按公司规模分類的监管事务市场

  • 规模大
  • 中等大小
  • 小规模

第12章监理事务市场：依最终用途

  • 生技公司
  • 医疗器材公司
  • 製药公司

第13章美洲监理事务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第14章亚太监管事务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第15章欧洲、中东和非洲监管事务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第16章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第17章上市公司名单

第18章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-0D217D5AEA7C

The Global Regulatory Affairs Market is forecasted to grow significantly, with a projected USD 15.63 billion in 2023 at a CAGR of 10.56% and expected to reach a staggering USD 31.71 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Regulatory Affairs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Regulatory Affairs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Services, market is studied across Legal Representation, Product Registration & Clinical Trial Applications, Regulatory Consulting, and Regulatory Writing & Publishing. The Product Registration & Clinical Trial Applications is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Cardiology, Immunology, Neurology, and Oncology. The Neurology is projected to witness significant market share during forecast period.

Based on Stage, market is studied across Clinical Studies and Preclinical. The Preclinical is projected to witness significant market share during forecast period.

Based on Category, market is studied across Biologics, Drugs, and Medical Devices. The Biologics is further studied across Biosimilars and Biotech. The Drugs is further studied across Generics and Innovator. The Medical Devices is further studied across Diagnostics and Therapeutics. The Biologics is projected to witness significant market share during forecast period.

Based on Service Provider, market is studied across In-House and Outsourced. The Outsourced is projected to witness significant market share during forecast period.

Based on Company Size, market is studied across Large, Medium, and Small. The Small is projected to witness significant market share during forecast period.

Based on End-Use, market is studied across Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies. The Medical Device Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Regulatory Affairs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Regulatory Affairs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Regulatory Affairs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Regulatory Affairs Market?

4. What is the competitive strategic window for opportunities in the Global Regulatory Affairs Market?

5. What are the technology trends and regulatory frameworks in the Global Regulatory Affairs Market?

6. What is the market share of the leading vendors in the Global Regulatory Affairs Market?

7. What modes and strategic moves are considered suitable for entering the Global Regulatory Affairs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Regulatory Affairs Market, by Services, 2022 vs 2030
  • 4.3. Regulatory Affairs Market, by Indication, 2022 vs 2030
  • 4.4. Regulatory Affairs Market, by Stage, 2022 vs 2030
  • 4.5. Regulatory Affairs Market, by Category, 2022 vs 2030
  • 4.6. Regulatory Affairs Market, by Service Provider, 2022 vs 2030
  • 4.7. Regulatory Affairs Market, by Company Size, 2022 vs 2030
  • 4.8. Regulatory Affairs Market, by End-Use, 2022 vs 2030
  • 4.9. Regulatory Affairs Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant growth in drug discovery and development worldwide
      • 5.1.1.2. Changing governmental regulatory landscapes for healthcare sector
      • 5.1.1.3. Rising prevalence of rare disorders and emergence of novel infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of delivering regulatory services
    • 5.1.3. Opportunities
      • 5.1.3.1. Massive investments by the key market players for development of healthcare equipment
      • 5.1.3.2. Increasing consumer preference for biologics and generic drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent governmental policies and regulations associated with regulatory affairs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Regulatory Affairs Market, by Services

  • 6.1. Introduction
  • 6.2. Legal Representation
  • 6.3. Product Registration & Clinical Trial Applications
  • 6.4. Regulatory Consulting
  • 6.5. Regulatory Writing & Publishing

7. Regulatory Affairs Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. Immunology
  • 7.4. Neurology
  • 7.5. Oncology

8. Regulatory Affairs Market, by Stage

  • 8.1. Introduction
  • 8.2. Clinical Studies
  • 8.3. Preclinical

9. Regulatory Affairs Market, by Category

  • 9.1. Introduction
  • 9.2. Biologics
    • 9.2.1. Biosimilars
    • 9.2.2. Biotech
  • 9.3. Drugs
    • 9.3.1. Generics
    • 9.3.2. Innovator
  • 9.4. Medical Devices
    • 9.4.1. Diagnostics
    • 9.4.2. Therapeutics

10. Regulatory Affairs Market, by Service Provider

  • 10.1. Introduction
  • 10.2. In-House
  • 10.3. Outsourced

11. Regulatory Affairs Market, by Company Size

  • 11.1. Introduction
  • 11.2. Large
  • 11.3. Medium
  • 11.4. Small

12. Regulatory Affairs Market, by End-Use

  • 12.1. Introduction
  • 12.2. Biotechnology Companies
  • 12.3. Medical Device Companies
  • 12.4. Pharmaceutical Companies

13. Americas Regulatory Affairs Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Regulatory Affairs Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Regulatory Affairs Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. FPNV Positioning Matrix
  • 16.2. Market Share Analysis, By Key Player
  • 16.3. Competitive Scenario Analysis, By Key Player

17. List of Company Mentioned

18. Appendix

  • 18.1. Discussion Guide
  • 18.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. REGULATORY AFFAIRS MARKET RESEARCH PROCESS
  • FIGURE 2. REGULATORY AFFAIRS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
  • FIGURE 5. REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 6. REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2022 VS 2030 (%)
  • FIGURE 7. REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2022 VS 2030 (%)
  • FIGURE 8. REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2022 VS 2030 (%)
  • FIGURE 9. REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2022 VS 2030 (%)
  • FIGURE 10. REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
  • FIGURE 11. REGULATORY AFFAIRS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 12. REGULATORY AFFAIRS MARKET DYNAMICS
  • FIGURE 13. REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 24. REGULATORY AFFAIRS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 25. REGULATORY AFFAIRS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. REGULATORY AFFAIRS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 5. REGULATORY AFFAIRS MARKET SIZE, BY LEGAL REPRESENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. REGULATORY AFFAIRS MARKET SIZE, BY PRODUCT REGISTRATION & CLINICAL TRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 10. REGULATORY AFFAIRS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. REGULATORY AFFAIRS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. REGULATORY AFFAIRS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. REGULATORY AFFAIRS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 15. REGULATORY AFFAIRS MARKET SIZE, BY CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. REGULATORY AFFAIRS MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 18. REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 19. REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. REGULATORY AFFAIRS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. REGULATORY AFFAIRS MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 23. REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. REGULATORY AFFAIRS MARKET SIZE, BY GENERICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. REGULATORY AFFAIRS MARKET SIZE, BY INNOVATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 27. REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. REGULATORY AFFAIRS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. REGULATORY AFFAIRS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 31. REGULATORY AFFAIRS MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. REGULATORY AFFAIRS MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 34. REGULATORY AFFAIRS MARKET SIZE, BY LARGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. REGULATORY AFFAIRS MARKET SIZE, BY MEDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. REGULATORY AFFAIRS MARKET SIZE, BY SMALL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. REGULATORY AFFAIRS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. REGULATORY AFFAIRS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 215. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 224. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 225. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 245. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 246. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 247. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 248. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 255. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 256. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 257. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 258. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 265. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 266. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 267. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 268. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 275. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 276. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 277. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 278. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 285. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 286. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 287. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 288. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 295. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 296. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 297. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 302. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 305. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 306. ITALY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 307. ITALY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 308. ITALY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 309. ITALY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 310. ITALY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 311. ITALY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 312. ITALY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 315. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 316. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 317. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 318. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 320. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 322. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 325. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 326. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 327. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 328. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 329. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 330. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 331. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 332. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 335. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 336. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 337. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 338. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 339. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 340. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 341. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 342. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 343. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 344. NORWAY REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 345. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 346. POLAND REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 347. POLAND REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 348. POLAND REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 349. POLAND REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 350. POLAND REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 351. POLAND REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 352. POLAND REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 353. POLAND REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
  • TABLE 354. POLAND REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 355. QATAR REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 356. QATAR REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 357. QATAR REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
  • TABLE 358. QATAR REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 359. QATAR REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
  • TABLE 360. QATAR REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 361. QATAR REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 362. QATAR REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 363. QATAR REGULATORY AFFAIRS MARKET SIZE, BY COMPANY